2001•University of Groningen research database (University of Groningen / Centre for Information Technology)Open access

Polymorphic drug metabolising enzymes: Assessment of activities by phenotyping and genotyping in clinical pharmacology

W.J. Tamminga

Abstract

Drug effects (pharmacodynamics) are determined by drug concentration at target site and the affinity of the drug for a target. Pharmacogenetics describes inherited differences in drug metabolising enzyme activities and differences in drug transporters and receptors.Answers were sought on the following questions:1. What is the value of genotyping on polymorphic drug metabolising enzymes compared to the classical phenotyping stategies?2. What is the situation concerning CYP2D6 and CYP2C19 polymorphism in the Dutch population?3. Is knowledge of the individual metaboliser status of CYP2D6 or CYP2C19 valuable in clinical pharmacological research and practice of pharmacotherapy

About this research paper

What this paper is about

Why it matters

OpenAlex reports 3 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: CYP2C19, Pharmacogenetics, CYP2D6, Pharmacology, Genotyping, Drug, Pharmacogenomics, Pharmacodynamics